The AstraZeneca stock price is hovering near $68 after the company presented at the American Society of Clinical Oncology (ASCO) meeting in Chicago this week.
ASCO is an annual event that's attended by 30,000 people and hosts more than 4,000 presentations. This year's meeting began on May 29 and ran through June 2.
The AstraZeneca stock price is hovering near $68 after the company presented at the American Society of Clinical Oncology (ASCO) meeting in Chicago this week.
ASCO is an annual event that's attended by 30,000 people and hosts more than 4,000 presentations. This year's meeting began on May 29 and ran through June 2.
AstraZeneca plc (NYSE: AZN) stock dropped as much as 15% today (Monday) following news that the British pharmaceutical company had rejected Pfizer Inc.'s (NYSE: PFE) final takeover offer.
The fact that a Pfizer AstraZeneca deal was once again rejected upset shareholders, who contributed to AstraZeneca stock's worst one-day performance ever.
Here’s what investors can expect to happen next....
